Jane Street’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Jane Street’s Portfolio CURE Stock Details CURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$886K	Buy	7,900 +1,300	+20%	+$122K	﹤0.01%	6787
2026 Q1	$604K	Buy	6,600 +200	+3%	+$21.7K	﹤0.01%	7601
2025 Q4	$714K	Buy	6,400 +1,700	+36%	+$174K	﹤0.01%	6909
2025 Q3	$393K	Buy	+4,700	New	+$366K	﹤0.01%	8357
2025 Q2	–	Sell	-3,000	Closed	-$320K	–	9795
2025 Q1	$320K	Buy	3,000 +800	+36%	+$85.1K	﹤0.01%	7694
2024 Q4	$203K	Sell	2,200 -600	-21%	-$67.6K	﹤0.01%	8386
2024 Q3	$373K	Buy	+2,800	New	+$360K	﹤0.01%	7689
2022 Q2	–	Sell	-17,700	Closed	-$2.31M	–	9793
2022 Q1	$2.31M	Buy	17,700 +7,500	+74%	+$893K	﹤0.01%	4470
2021 Q4	$1.48M	Sell	10,200 -14,800	-59%	-$1.8M	﹤0.01%	5120
2021 Q3	$2.69M	Buy	25,000 +20,000	+400%	+$2.41M	﹤0.01%	3885
2021 Q2	$523K	Sell	5,000 -500	-9%	-$48K	﹤0.01%	7152
2021 Q1	$459K	Sell	5,500 -800	-13%	-$64.5K	﹤0.01%	6958
2020 Q4	$485K	Sell	6,300 -12,500	-66%	-$860K	﹤0.01%	5791
2020 Q3	$1.19M	Buy	18,800 +1,300	+7%	+$81.6K	﹤0.01%	3812
2020 Q2	$951K	Buy	17,500 +8,900	+103%	+$472K	﹤0.01%	4135
2020 Q1	$343K	Sell	8,600 -5,300	-38%	-$334K	﹤0.01%	4064
2019 Q4	$1.02M	Buy	13,900 +9,200	+196%	+$562K	﹤0.01%	2746
2019 Q3	$238K	Sell	4,700 -2,600	-36%	-$138K	﹤0.01%	4444
2019 Q2	$410K	Sell	7,300 -2,700	-27%	-$139K	﹤0.01%	3826
2019 Q1	$556K	Sell	10,000 -9,800	-49%	-$521K	﹤0.01%	3561
2018 Q4	$942K	Buy	+19,800	New	+$1.11M	﹤0.01%	2651
2016 Q3	–	Sell	-19,600	Closed	-$620K	–	4053
2016 Q2	$620K	Hold	19,600	–	–	﹤0.01%	2532
2016 Q1	$532K	Buy	+19,600	New	+$516K	﹤0.01%	2532
2015 Q4	–	Sell	-9,000	Closed	-$238K	–	4044
2015 Q3	$238K	Buy	+9,000	New	+$330K	﹤0.01%	3007
2015 Q2	–	Sell	-45,000	Closed	-$1.32M	–	3669
2015 Q1	$1.32M	Buy	+45,000	New	+$1.26M	0.01%	1154
2014 Q3	–	Sell	-21,500	Closed	-$385K	–	2596
2014 Q2	$385K	Sell	21,500 -51,000	-70%	-$822K	﹤0.01%	1621
2014 Q1	$1.16M	Buy	+72,500	New	+$1.12M	0.01%	852

Other funds holding CURE

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

LFG

Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return

OBWG

Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Jane Street's CURE Position: Q2 2026 in Review

Jane Street increased its Direxion Daily Healthcare Bull 3X ETF (CURE) stake by 650% in Q2 2026, buying an estimated $2.05M and bringing the position to 25,141 shares worth $2.82M. The position accounts for ﹤0.01% of the portfolio, ranked #4603.

Jane Street first reported a position in CURE in Q1 2014 and has held it in 23 quarters since. The position peaked at $4.56M in Q4 2025. 19 funds tracked by Wall St. Rank hold CURE as of Q2 2026.

Jane Street held 25,141 shares of Direxion Daily Healthcare Bull 3X ETF worth $2.82M as of Q2 2026.
Jane Street bought 21,790 Direxion Daily Healthcare Bull 3X ETF shares in Q2 2026, an estimated $2.05M.
Direxion Daily Healthcare Bull 3X ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4603 holding.
Jane Street first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2014 and has held it in 23 quarters since.
Jane Street's Direxion Daily Healthcare Bull 3X ETF position peaked at $4.56M in Q4 2025.
19 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.